You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 755 DEKA-1 a dose-finding Phase 1 trial: observing safety and biomarkers using DK210 (EGFR) for inoperable locally advanced and/or metastatic EGFR+ tumors failing systemic therapy

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
755 DEKA-1 a dose-finding Phase 1 trial: observing safety and biomarkers using DK210 (EGFR) for inoperable locally advanced and/or metastatic EGFR+ tumors failing systemic therapy

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023150013
Dec 20232806
Jan 20245907
Feb 20245404
Mar 202422010
Apr 20245403
May 20243304
Jun 20244604
Jul 20241400
Aug 20243405
Sep 20242803
Oct 20244208
Nov 20247205
Dec 20243009
Jan 20253805
Feb 20251806
Mar 2025002
Apr 2025002
May 2025107
Jun 2025103
Total7240106